Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Revenue
$656.40M
Quarterly · Period ending: · USD
BIO Revenue
Latest reported$656.40Mperiod ending
Latest reported$656.40Mperiod ending
BIO Quarterly Revenue ($25.40M → $656.40M)
Quarterly revenue
High-resolution chart · PNG
BIO revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Revenue (USD) |
|---|---|
| 186,104,000 | |
| 195,354,000 | |
| 202,668,000 | |
| 183,025,000 | |
| 174,086,000 | |
| 185,087,000 | |
| 183,686,000 | |
| 194,400,000 | |
| 113,500,000 | |
| 115,800,000 | |
| 125,700,000 | |
| 118,800,000 | |
| 99,000,000 | |
| 107,900,000 | |
| 116,200,000 | |
| 115,800,000 | |
| 99,500,000 | |
| 105,800,000 | |
| 105,900,000 | |
| 114,000,000 | |
| 96,600,000 | |
| 100,000,000 | |
| 108,300,000 | |
| 107,900,000 | |
| 92,900,000 | |
| 97,900,000 | |
| 97,900,000 | |
| 96,700,000 | |
| 83,800,000 | |
| 85,100,000 | |
| 89,700,000 | |
| 87,300,000 | |
| 78,900,000 | |
| 81,800,000 | |
| 80,500,000 | |
| 88,100,000 | |
| 78,600,000 | |
| 80,000,000 | |
| 83,600,000 | |
| 82,400,000 | |
| 75,100,000 | |
| 76,500,000 | |
| 76,700,000 | |
| 80,300,000 | |
| 69,500,000 | |
| 68,800,000 | |
| 68,100,000 | |
| 64,800,000 | |
| 55,100,000 | |
| 60,000,000 | |
| 56,300,000 | |
| 53,300,000 | |
| 46,200,000 | |
| 49,000,000 | |
| 50,500,000 | |
| 44,100,000 | |
| 39,000,000 | |
| 38,900,000 | |
| 37,500,000 | |
| 34,000,000 | |
| 31,100,000 | |
| 31,400,000 | |
| 30,000,000 | |
| 27,200,000 | |
| 25,400,000 |